Atlas Arteria (MAQAF) Stock Price, News & Analysis

Company Overview

Atlas Arteria (OTCMKTS:MAQAF) is an international toll-road owner and operator headquartered in Australia. Through its portfolio of infrastructure investments, the company manages and operates road networks that generate revenue from electronic and conventional tolling, while providing motorists with access to major transport corridors.

The company’s principal interests include toll-road assets in France, Germany and the United States. Its French operations include interests in the APRR and AREA motorway networks, which connect major cities and commercial regions across eastern and southeastern France. Atlas Arteria has also owned or operated assets such as the Warnow Tunnel in Germany and the Dulles Greenway in Virginia. Its portfolio has changed over time as the company has pursued asset sales and other strategic transactions.

Atlas Arteria was established as Macquarie Atlas Roads in 2005 and adopted its current name in 2018. The company focuses on the long-term ownership, development and operation of transportation infrastructure, with an emphasis on maintaining road availability, improving customer service and supporting efficient movement of people and goods.

Key Stats

• Today's Range: $3.08 to $3.08
• 50-Day Range: $3.08 to $3.68
• 52-Week Range: $2.69 to $4.09
• Volume: N/A
• Average Volume: 1,235 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 2.69%
• Price Target: $5.03
• Consensus Rating: Hold

Atlas Arteria Stock Analysis - MarketRank™

Atlas Arteria scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Atlas Arteria has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Atlas Arteria has a consensus price target of $5.03, representing about 63.3% upside from its current price of $3.08.

Amount of Analyst Coverage

Atlas Arteria has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Atlas Arteria is -29.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Atlas Arteria is -29.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Atlas Arteria has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Atlas Arteria has recently decreased by 7.94%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Atlas Arteria is a leading dividend payer. It pays a dividend yield of 5.02%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Atlas Arteria does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Atlas Arteria insiders have not sold or bought any company stock.

Percentage Held by Institutions

24.06% of the stock of Atlas Arteria is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Infrastructure Operations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MAQAF
• CIK: N/A
• Web: www.atlasarteria.com
• Phone: 611800621694
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Atlas Arteria: $5.03
• High Price Target: $5.31
• Low Price Target: $4.75
• Potential Upside/Downside: +63.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A